<DOC>
	<DOCNO>NCT01382225</DOCNO>
	<brief_summary>The purpose study determine Sodium Hyaluronate , 0.18 % effective treating sign symptom dry eye disease .</brief_summary>
	<brief_title>Sodium Hyaluronate Ophthalmic Solution , 0.18 % Treatment Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Documented history dry eye least 3 month . Ocular discomfort due dry eye . Presence corneal conjunctival staining . Other protocoldefined inclusion criterion may apply . Women pregnant lactating . Contact lens wear within 1 week Screening study . Ocular surgery ( type , include laser surgery ) ocular trauma within 4 month prior Screening . Punctal plugs punctal occlusion initiate within 3 month screen Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Ocular discomfort</keyword>
</DOC>